Table 3.
HIV-related characteristics of VL–HIV co-infected patients diagnosed at the Metema hospital, northwest Ethiopia, 2010–2014 (N = 58)
| Variable | VL after HIV diagnosis (N = 11) | Concurrent VL/HIV diagnosis (N = 47) (%) |
|---|---|---|
| Median (IQR) or N (%) | Median (IQR) or N | |
| Time from HIV to VL diagnosis (months) | 18 (6–32) | NA |
| CD4 count at HIV diagnosis; cells/µL | 346 (137–402) | 143 (59–334) |
| Missing | 1 | 16 |
| CD4 count at VL diagnosis; cells/µL | 248 (160–340) | 143 (59–333) |
| Missing | 3 | 16 |
| Tuberculosis at HIV diagnosis | 3 (27%) | 4 (9%) |
| ART initiation | ||
| Never | 2 (18%) | 34 (74%) |
| Before VL | 7 (64%) | NA |
| Time between VL and ART | 17 (3–37) | NA |
| CD4 count at HIV diagnosis; cells/µL | – | – |
| CD4 count at ART initiation; cells/µL (N = 3) | 239 (133–585) | – |
| CD4 count at VL diagnosis; cells/µL (N = 6) | – | – |
| After VL* | 2 (18%) | 13 (28%) |
| Time between first VL and ART (months); | 1.7; 31.8 | 2.0 (1.3–3.8) |
| CD4 count at ART initiation; cells/µL | 52; 183 | 102 (40–172) |
| Missing | 0 | 5 |
| Outcome of first VL episode | ||
| Improved and discharged | 5 (45%) | 25 (53%) |
| Died | 0 | 10 (21%) |
| Failed | 0 | 0 |
| Referred | 4 (36%) | 10 (21%) |
| Absconded | 0 | 1 (2%) |
| Unknown | 2 (18%) | 4 (8%) |
| Relapse after first episode | 1 (9%) | 4 (8%) |
ART = antiretroviral treatment; IQR = interquartile range; VL = visceral leishmaniasis.
*
If N ≤ 2, the values are given (i.e., no median is calculated).